Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Koch

Showing results (551-560 of 726) with videos related to

Pageof 73
Sort By:
Medical Mycology|February 14, 2019
Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patientsVincent J Lempers, Edmé Meuwese, Annelies M Mavinkurve-Groothuis, et al.
BMC Infectious Diseases|January 19, 2020
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trialA Abdulla, T M J Ewoldt, N G M Hunfeld, et al.
Critical Care (London, England)|September 16, 2020
Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)Alan Abdulla, Annemieke Dijkstra, Nicole G M Hunfeld, et al.
British Journal of Clinical Pharmacology|February 9, 2017
Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?Linda G Franken, Anniek D Masman, Brenda C M de Winter, et al.
Clinical Orthopaedics and Related Research|January 30, 2024
In Vitro Elution of Gentamicin from CERAMENT® G Has an Antimicrobial Effect on Bacteria With Various Levels of Gentamicin Resistance Found in Fracture-related InfectionHans Bezstarosti, Esther M M Van Lieshout, Maartje J B Van den Hurk, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 5, 2023
Clinical pharmacokinetics of antipsychotics in pediatric populations: a scoping review focusing on dosing regimenJiayi Liang, Lisa T Ringeling, Rebecca A Hermans, et al.
Clinical Pharmacokinetics|July 5, 2022
Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain-Barré SyndromeWillem Jan R Fokkink, Sander J van Tilburg, Brenda C M de Winter, et al.
Therapeutic Drug Monitoring|September 5, 2025
Quantification of Vancomycin and Clindamycin in Synovial Tissue and Bone Using Ultra-High-Performance Liquid Chromatography-Tandem Mass SpectrometryAmanda J Holst, Soma Bahmany, Angela C J van Dorp, et al.
Journal of Cancer Research and Clinical Oncology|June 11, 1999
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.
European Journal of Clinical Pharmacology|March 4, 2018
Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungalsFerdows Atiq, Edon Hameli, Annoek E C Broers, et al.
Pageof 73

Showing results (551-560 of 726) with videos related to

Sort By:
Pageof 73
Medical Mycology|February 14, 2019
Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patientsVincent J Lempers, Edmé Meuwese, Annelies M Mavinkurve-Groothuis, et al.
BMC Infectious Diseases|January 19, 2020
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trialA Abdulla, T M J Ewoldt, N G M Hunfeld, et al.
Critical Care (London, England)|September 16, 2020
Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)Alan Abdulla, Annemieke Dijkstra, Nicole G M Hunfeld, et al.
British Journal of Clinical Pharmacology|February 9, 2017
Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?Linda G Franken, Anniek D Masman, Brenda C M de Winter, et al.
Clinical Orthopaedics and Related Research|January 30, 2024
In Vitro Elution of Gentamicin from CERAMENT® G Has an Antimicrobial Effect on Bacteria With Various Levels of Gentamicin Resistance Found in Fracture-related InfectionHans Bezstarosti, Esther M M Van Lieshout, Maartje J B Van den Hurk, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 5, 2023
Clinical pharmacokinetics of antipsychotics in pediatric populations: a scoping review focusing on dosing regimenJiayi Liang, Lisa T Ringeling, Rebecca A Hermans, et al.
Clinical Pharmacokinetics|July 5, 2022
Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain-Barré SyndromeWillem Jan R Fokkink, Sander J van Tilburg, Brenda C M de Winter, et al.
Therapeutic Drug Monitoring|September 5, 2025
Quantification of Vancomycin and Clindamycin in Synovial Tissue and Bone Using Ultra-High-Performance Liquid Chromatography-Tandem Mass SpectrometryAmanda J Holst, Soma Bahmany, Angela C J van Dorp, et al.
Journal of Cancer Research and Clinical Oncology|June 11, 1999
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.
European Journal of Clinical Pharmacology|March 4, 2018
Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungalsFerdows Atiq, Edon Hameli, Annoek E C Broers, et al.
Pageof 73